HUMANITAS MIRASOLE SPA
🇮🇹Italy
Open Label Extension of TUDCA-ALS Study
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Humanitas Mirasole SpA
- Target Recruit Count
- 184
- Registration Number
- NCT05753852
- Locations
- 🇧🇪
Katholieke Universiteit Leuven, Leuven, Belgium
🇮🇹AOU Città della Salute e della Scienza di Torino, Torino, Italy
🇬🇧University of Sheffield, Sheffield, United Kingdom
Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2019-01-11
- Last Posted Date
- 2023-07-10
- Lead Sponsor
- Humanitas Mirasole SpA
- Target Recruit Count
- 337
- Registration Number
- NCT03800524
- Locations
- 🇩🇪
Alfried Krupp Krankenhaus Rüttenscheid, Essen, Germany
🇩🇪Medizinische Hochschule Hannover, Hannover, Germany
🇬🇧The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath